Chularat Hospital Public Company Limited (SET: CHG) has announced 2Q25 consolidated financial statement through the Stock Exchange of Thailand as follows:
| Quarter | 2Q25 | 2Q24 |
| Net Profit (Loss)
Million Baht |
207.65 | 192.26 |
| Earning Per Share
(Baht) |
0.0189 | 0.0175 |
| % Change | 8.01 | |
| 6 Month | 2025 | 2024 |
| Net Profit (Loss)
Million Baht |
432.98 | 456.22 |
| Earning Per Share (Baht) | 0.04 | 0.04 |
| % Change | -5.09 | |
CHG reported a net profit in 2Q25 of Baht 207.65 million, an increase of Baht 15.39 million or 8.01% compared to the previous year.
In 2Q25, the Company had revenues from hospital operations of Baht 2,012.1 million, increasing by Baht 26.6 million, or 1% YoY, driven by the increasing revenue from general patients and the Universal Health Coverage Scheme (NHSO).
In 2Q25, the termination of the Pattaya City Hospital Project was a key factor contributing to a significant reduction in personnel costs, both in headcount and related expenses, while also allowing for the direct elimination of certain fixed costs. In addition, the Company implemented effective cost management in medical treatment services, resulting in a total cost reduction of Baht 67.5 million.
The cost reductions played a significant role in improving the gross profit margin and strengthening the company’s long-term profitability
